124 related articles for article (PubMed ID: 17391387)
1. The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin.
Cateau E; Levasseur P; Borgonovi M; Imbert C
Clin Microbiol Infect; 2007 Mar; 13(3):311-5. PubMed ID: 17391387
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.
Soustre J; Rodier MH; Imbert-Bouyer S; Daniault G; Imbert C
J Antimicrob Chemother; 2004 Mar; 53(3):522-5. PubMed ID: 14749343
[TBL] [Abstract][Full Text] [Related]
3. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
4. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
Ghannoum MA; Kim HG; Long L
J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
[TBL] [Abstract][Full Text] [Related]
6. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
Arai R; Sugita T; Nishikawa A
Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
Seidler M; Salvenmoser S; Müller FM
Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro MA; Paula CR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of secretory aspartyl protease production in biofilms of Candida albicans exposed to sub-inhibitory concentrations of fluconazole.
Mores AU; Souza RD; Cavalca L; de Paula e Carvalho A; Gursky LC; Rosa RT; Samaranayake LP; Rosa EA
Mycoses; 2011 May; 54(3):195-201. PubMed ID: 19878458
[TBL] [Abstract][Full Text] [Related]
14. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
15. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers.
Lyon JP; de Resende MA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):632-8. PubMed ID: 17052640
[TBL] [Abstract][Full Text] [Related]
16. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
17. Acquired resistance to echinocandins in Candida albicans: case report and review.
Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
[TBL] [Abstract][Full Text] [Related]
18. Influence of cell surface hydrophobicity on attachment of Candida albicans to extracellular matrix proteins.
Silva TM; Glee PM; Hazen KC
J Med Vet Mycol; 1995; 33(2):117-22. PubMed ID: 7658302
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.
Wildfeuer A; Seidl HP
Arzneimittelforschung; 1995 Jul; 45(7):819-21. PubMed ID: 8573230
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
